RxDoctor Payments Data

Jorge Gonzalez-Martinez, MD

Neurological Surgery · Pittsburgh, PANPI 1467629444

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,619 of the $64,886 with a category attached, or 68.8%. Zimmer Biomet accounts for 71.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $18,376 and has fallen 99.2% since, to $148 in 2025.

$64,886in general payments, 2019–2025

Across 94 payments — averaging $690.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$46K
  • DIXI Medical USA Corp$11K
  • Monteris Medical Corporation$6K
  • Boston Scientific$669
  • Medtronic$363
  • Neuropace, Inc.$282
  • plus $185 from 2 others
$81,117in research payments, 2019–2025

Across 7 payments — averaging $11,588 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$81K

What the payments were for

  • Consulting fees$44,61969%
  • Grants$2420%
  • Travel & lodging$8,27413%
  • Food & beverage$6,25110%
  • Education$5,5008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet52$46,304
DIXI Medical USA Corp16$10,604
Monteris Medical Corporation10$6,479
Boston Scientific10$669
Medtronic2$363
Neuropace, Inc.2$282
Livanova USA, Inc.1$96
Smith+Nephew1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,886 in reported general payments places this provider in the 85th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$60,425
Medicare patients
52
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin17$134

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →